{"id":"W4408080074","doi":"10.1016/j.breast.2025.104432","title":"A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026)","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Association of Schools and Colleges of Optometry; Breakthrough Cancer Research; Translational Breast Cancer Research Consortium; Susan G. Komen; AbbVie; Breast Cancer Research Foundation; National Cancer Institute; Conquer Cancer Foundation; Sidney Kimmel Comprehensive Cancer Center; Genentech; Susan G. Komen for the Cure","keywords":"Medicine; Pertuzumab; Trastuzumab; Breast cancer; Oncology; Biomarker; Internal medicine; Neoadjuvant therapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001187358,0.0003950821,0.0006182645,0.0005379874,0.0002228235,0.000121255,0.0003132414,0.00003322532,0.0002409595],"category_scores_gemma":[0.000111035,0.0002960861,0.00006705857,0.001105839,0.0003422014,0.00008026034,0.000297399,0.0004657636,0.00003576256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009491685,"about_ca_system_score_gemma":0.0009394378,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007373916,"about_ca_topic_score_gemma":0.001349565,"domain_scores_codex":[0.9968743,0.0005902405,0.0003967057,0.0007701778,0.0006133319,0.000755281],"domain_scores_gemma":[0.9980379,0.0004948114,0.00005424606,0.0006621376,0.0001984514,0.0005524384],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1459177,0.001658611,0.2401105,0.001219426,0.000878657,0.009097365,0.005149802,0.0003472329,0.129579,0.0001040411,0.02836866,0.437569],"study_design_scores_gemma":[0.00444793,0.0006934076,0.9738538,0.002665759,0.0001268524,0.007030535,0.0005369514,0.001632086,0.002232082,0.00001807682,0.00642102,0.0003414548],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9124891,0.0009590716,0.00008398993,0.08242516,0.0001253032,0.002057798,0.0008358004,0.00007881536,0.0009449545],"genre_scores_gemma":[0.9940299,0.00006772156,0.000185798,0.003221442,0.00008609787,0.0002708585,0.00001888399,0.00006386232,0.002055387],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7337434,"threshold_uncertainty_score":0.9999491,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01518711006540524,"score_gpt":0.3401464071977882,"score_spread":0.3249592971323829,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}